Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MNOV [NASD]
MediciNova Inc.
Index- P/E- EPS (ttm)-0.17 Insider Own17.75% Shs Outstand24.13M Perf Week-1.52%
Market Cap46.81M Forward P/E- EPS next Y- Insider Trans3.62% Shs Float40.81M Perf Month1.04%
Income-4.00M PEG- EPS next Q- Inst Own9.10% Short Float0.45% Perf Quarter-3.48%
Sales6.00M P/S7.80 EPS this Y71.20% Inst Trans-0.05% Short Ratio8.28 Perf Half Y-19.17%
Book/sh1.12 P/B1.73 EPS next Y- ROA-14.00% Target Price6.00 Perf Year-27.88%
Cash/sh0.61 P/C3.16 EPS next 5Y20.00% ROE-16.60% 52W Range1.66 - 5.25 Perf YTD-9.35%
Dividend- P/FCF- EPS past 5Y36.40% ROI-15.70% 52W High-63.05% Beta1.04
Dividend %- Quick Ratio17.90 Sales past 5Y- Gross Margin- 52W Low16.87% ATR0.08
Employees11 Current Ratio17.90 Sales Q/Q- Oper. Margin-66.70% RSI (14)47.70 Volatility2.72% 3.98%
OptionableNo Debt/Eq0.00 EPS Q/Q28.60% Profit Margin-66.70% Rel Volume0.28 Prev Close1.94
ShortableYes LT Debt/Eq0.00 EarningsAug 04 Payout- Avg Volume22.04K Price1.94
Recom1.00 SMA20-2.93% SMA50-0.46% SMA200-10.31% Volume6,175 Change0.00%
04-Jan-13Reiterated Ladenburg Thalmann Buy $10.50 → $6
24-May-12Downgrade MLV & Co Buy → Hold
18-Oct-11Reiterated MLV Capital Buy $13 → $6
22-Jun-11Initiated Global Hunter Securities Buy $4
12-May-10Initiated Wedbush Outperform $13
12-Nov-08Reiterated Ladenburg Thalmann Buy $22 → $6
15-May-08Initiated Rodman & Renshaw Mkt Outperform $9
09-Jul-07Initiated Punk, Ziegel & Co Buy $22
11-Jul-14 05:15PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and EDGAR Online
07-Jul-14 07:00PM  MediciNova to Present Data on MN-001 for the Treatment of NASH (Nonalcoholic Steatohepatitis) During the JDDW 2014 (Japan Digestive Disease Week 2014) GlobeNewswire
17-Jun-14 05:29PM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secu EDGAR Online
05:29PM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secu
11-Jun-14 07:00PM  MediciNova Announces Positive Results in Study of MN-001 in Mouse Model of Pulmonary Fibrosis GlobeNewswire
07:00PM  MediciNova Announces Positive Results in Study of MN-001 in Mouse Model of Pulmonary Fibrosis
16-May-14 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
01:04PM  MEDICINOVA INC Financials
09-May-14 10:33AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
10:33AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure
08-May-14 05:05PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
05:05PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report
09-Apr-14 06:01AM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic EDGAR Online
06:01AM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic
08-Apr-14 07:00PM  MediciNova Appoints Yoshio Ishizaka to its Board of Directors GlobeNewswire +9.04%
07:00PM  MediciNova Appoints Yoshio Ishizaka to its Board of Directors
07:00PM  MediciNova Announces Management Appointment GlobeNewswire
07:00PM  MediciNova Announces Management Appointment
11:00AM  Treatments for Non-Alcoholic Steatohepatitis Making Clinical Strides Accesswire
11:00AM  Treatments for Non-Alcoholic Steatohepatitis Making Clinical Strides
03-Apr-14 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
28-Mar-14 06:07AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
06:07AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure
27-Mar-14 05:04PM  MEDICINOVA INC Files SEC form 10-K, Annual Report EDGAR Online
10-Mar-14 09:00AM  MEDICINOVA INC Files SEC form 8-K, Other Events EDGAR Online
25-Feb-14 04:47PM  MediciNova: Gestation Is Slow And Uncomfortable - Birth Is Sudden And Unexpected at Seeking Alpha
04:47PM  MediciNova: Gestation Is Slow And Uncomfortable - Birth Is Sudden And Unexpected
17-Jan-14 03:52PM  Five Worst, Pandering Drug Stocks of J.P. Morgan Healthcare Confab Week at TheStreet
03:52PM  Five Worst, Pandering Drug Stocks of J.P. Morgan Healthcare Confab Week
14-Jan-14 08:00AM  MediciNova Announces Positive Results in NASH Mouse Model With MN-001 and Prepares to Initiate Phase 2 Trial in the U.S. GlobeNewswire +32.09%
08:00AM  MediciNova Announces Positive Results in NASH Mouse Model With MN-001 and Prepares to Initiate Phase 2 Trial in the U.S.
13-Jan-14 05:16PM  MEDICINOVA INC Files SEC form 8-K, Other Events EDGAR Online
05:16PM  MEDICINOVA INC Files SEC form 8-K, Other Events
30-Dec-13 06:10AM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
06:10AM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers
13-Dec-13 06:07AM  MediciNova (MNOV) Jumps: Stock Adds 22.2% in Session Zacks -10.98%
06:07AM  MediciNova (MNOV) Jumps: Stock Adds 22.2% in Session
15-Nov-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
01:04PM  MEDICINOVA INC Financials
13-Nov-13 06:02AM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic EDGAR Online
06:02AM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic
11-Nov-13 06:00PM  MediciNova Receives New Patent Covering MN-221 in Irritable Bowel Syndrome GlobeNewswire
06:00PM  MediciNova Receives New Patent Covering MN-221 in Irritable Bowel Syndrome
08-Nov-13 06:19AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online -6.11%
06:19AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure
07-Nov-13 06:30PM  MediciNova Reports Third Quarter 2013 Results GlobeNewswire
06:30PM  MediciNova Reports Third Quarter 2013 Results
05:17PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
05:17PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report
18-Oct-13 03:19PM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
03:19PM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
16-Oct-13 05:00PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive A EDGAR Online +5.04%
05:00PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive A
05:00PM  MediciNova Appoints Yutaka Kobayashi to Its Board of Directors GlobeNewswire
04:30PM  InPlay: MediciNova appoints Geoffrey O'Brien as Vice President Briefing.com
04:30PM  MediciNova Appoints Geoffrey O'Brien as Vice President GlobeNewswire
06-Oct-13 07:00PM  MediciNova Receives Notice of Allowance for New Patent Covering MN-029 (denibulin) di-hydrochloride GlobeNewswire
26-Sep-13 04:17PM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
25-Aug-13 07:00PM  National Institute on Alcohol Abuse and Alcoholism Funds New UCLA Clinical Trial of MediciNova's MN-166 in Treating Alcoholism GlobeNewswire
20-Aug-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
09-Aug-13 09:01AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
08-Aug-13 05:30PM  MediciNova Reports Second Quarter 2013 Results GlobeNewswire
05:11PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
30-Jul-13 09:02AM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
18-Jul-13 07:00PM  MediciNova Announces Initiation of a Cooperative Phase 2b Trial of MN-166 in Progressive Multiple Sclerosis GlobeNewswire
17-Jul-13 09:03AM  MEDICINOVA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
20-Jun-13 06:48PM  Nasdaq stocks posting largest volume increases AP -11.87%
19-Jun-13 06:05PM  Nasdaq stocks posting largest volume increases AP +31.13%
05:15PM  MediciNova Presents MN-166 Data Zacks
18-Jun-13 06:04PM  InPlay: MediciNova: UCLA presents data on MediciNova's MN-166 in methamphetamine addicition Briefing.com
06:00PM  UCLA Presents Data on MediciNova's MN-166 in Methamphetamine Addiction at the 75th Annual Meeting of the College on Problems of Drug Dependence GlobeNewswire
17-Jun-13 07:32AM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secu EDGAR Online
07-Jun-13 10:21AM  MEDICINOVA INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tr EDGAR Online
14-May-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials -6.10%
13-May-13 01:34PM  Monday Sector Leaders: Biotechnology, Drugs at Forbes +16.48%
09-May-13 11:13PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities EDGAR Online -26.78%
02:01AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
08-May-13 05:30PM  MediciNova Reports First Quarter 2013 Results GlobeNewswire +10.50%
10:10AM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
18-Apr-13 06:35AM  MedicNova enters into 6M equity distribution agreement with Macquarie at theflyonthewall.com +6.72%
17-Apr-13 11:19PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
09:08AM  MEDICINOVA INC Files SEC form 8-K, Other Events EDGAR Online
03-Apr-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
29-Mar-13 02:02AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
28-Mar-13 05:30PM  MediciNova Reports Fourth Quarter and Full Year 2012 Results GlobeNewswire
10:16AM  MEDICINOVA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
10:08AM  MEDICINOVA INC Files SEC form 10-K, Annual Report EDGAR Online
21-Mar-13 01:23AM  InPlay: MediciNova presents data from MN-166 opioid withdrawal and analgesia data Briefing.com
20-Mar-13 07:00PM  MediciNova Announces MN-166 (ibudilast) Opioid Withdrawal and Analgesia Data Presentation at the American Academy of Neurology Annual Meeting GlobeNewswire +5.71%
03-Mar-13 08:32AM  5 of Last Week's Biggest Winners at Motley Fool
01-Mar-13 05:02PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online -12.35%
28-Feb-13 03:24PM  Thursdays movers: Herbalife gets more Icahn lift at MarketWatch +7.59%
01:45PM  Thursdays movers: Sears covered in red ink at MarketWatch
11:18AM  Thursdays movers: J.C. Penney is S&P 500 laggard at MarketWatch
10:27AM  Thursdays movers: Groupon sinks on surprise loss at MarketWatch
09:09AM  Thursdays biggest gaining and declining stocks at MarketWatch
27-Feb-13 06:02PM  Nasdaq stocks posting largest volume increases AP +6.04%
01:49PM  Secretive Dilution And A Possible Equity Financing From MediciNova at Seeking Alpha
08:20AM  Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwired
08:20AM  Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwire
MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a 2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.